April 20, 2017

Q2 Solutions Anti-infective and Vaccine Development Services

With emerging and re-emerging infectious diseases, the development of new anti-infectives and vaccines presents many challenges. Q2 Solutions understands these challenges in vaccine development. Our scientific experts can provide you with the strategic guidance to develop and validate custom assays and the high-quality laboratory services you need to ensure optimum data delivery and regulatory success.

Download this brochure to learn how we integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize your anti-infective or vaccine study design.

Related Services:
Harnessing innovative technologies for clinical trials involving emerging and re-emerging infectious diseases

Tools for better management of infectious disease clinical trials

Assays to drive success in anti-infective and vaccine development

Extensive expertise for vaccine assay development and diagnostics

Keeping Up with the Flu: Advances in seasonal influenza vaccine development

Read More